1. Home
  2. SER vs LOAN Comparison

SER vs LOAN Comparison

Compare SER & LOAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SER
  • LOAN
  • Stock Information
  • Founded
  • SER 2017
  • LOAN 1989
  • Country
  • SER United States
  • LOAN United States
  • Employees
  • SER N/A
  • LOAN N/A
  • Industry
  • SER Biotechnology: Pharmaceutical Preparations
  • LOAN Real Estate Investment Trusts
  • Sector
  • SER Health Care
  • LOAN Real Estate
  • Exchange
  • SER Nasdaq
  • LOAN Nasdaq
  • Market Cap
  • SER 55.2M
  • LOAN 61.0M
  • IPO Year
  • SER 2018
  • LOAN 1999
  • Fundamental
  • Price
  • SER $5.00
  • LOAN $4.92
  • Analyst Decision
  • SER Strong Buy
  • LOAN
  • Analyst Count
  • SER 2
  • LOAN 0
  • Target Price
  • SER $13.00
  • LOAN N/A
  • AVG Volume (30 Days)
  • SER 43.2K
  • LOAN 44.5K
  • Earning Date
  • SER 11-11-2025
  • LOAN 10-24-2025
  • Dividend Yield
  • SER N/A
  • LOAN 9.35%
  • EPS Growth
  • SER N/A
  • LOAN N/A
  • EPS
  • SER N/A
  • LOAN 0.46
  • Revenue
  • SER $130,000.00
  • LOAN $7,138,128.00
  • Revenue This Year
  • SER $134.46
  • LOAN N/A
  • Revenue Next Year
  • SER N/A
  • LOAN $4.47
  • P/E Ratio
  • SER N/A
  • LOAN $10.63
  • Revenue Growth
  • SER N/A
  • LOAN N/A
  • 52 Week Low
  • SER $3.81
  • LOAN $4.74
  • 52 Week High
  • SER $7.92
  • LOAN $6.05
  • Technical
  • Relative Strength Index (RSI)
  • SER 48.12
  • LOAN 28.91
  • Support Level
  • SER $4.60
  • LOAN $4.83
  • Resistance Level
  • SER $5.01
  • LOAN $5.19
  • Average True Range (ATR)
  • SER 0.24
  • LOAN 0.12
  • MACD
  • SER -0.02
  • LOAN -0.04
  • Stochastic Oscillator
  • SER 57.97
  • LOAN 15.62

About SER Serina Therapeutics Inc.

Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The Company has one reportable segment relating to the research and development of its POZ platform.

About LOAN Manhattan Bridge Capital Inc

Manhattan Bridge Capital Inc is a real estate finance company taxed as a REIT that specializes in originating, servicing and managing a portfolio of first mortgage loans. The company offers short-term, secured, non-banking loans which may renew or extend, before or after their initial term expires, to real estate investors to fund their acquisition, renovation, rehabilitation or development of residential or commercial properties located in the New York metropolitan area, including New Jersey and Connecticut, and in Florida.

Share on Social Networks: